The in vitro activities of two new antimicrobial agents, apalcillin and cefpiramide (SM-1652), were evaluated against 324 strains of anaerobic bacteria. Apalcillin (a penicillin derivative) and cefpiramide (a semisynthetic cephalosporin) were compared with piperacillin, moxalactam, and cefoxitin. Organisms studied included the Bacteroides fragilis group, other Bacteroides species, fusobacteria, clostridia, nonsporeforming gram-positive rods, and anaerobic cocci. Piperacillin was found to be the most active overall, inhibiting 96% of the strains tested at its achievable level in serum (128 p.g/ml). Apalcillin was comparable in activity to piperacillin, inhibiting 93% of anaerobes tested at this concentration. The other antibiotics inhibited ca. 80% of the strains at 32 pLg/ml. In terms of activities against particular species, apalcillin was active against 75% of B. fragilis group strains and 97 to 100%o of all other anaerobes. Cefpiramide inhibited 37% of B. fragilis group strains at 32 Lg/ml and 68% at 64 pg/ml (a level that may be achievable with this drug). Cefpiramide inhibited 92% of all other anaerobes at 32 ,ug/ml and 95% at 64 ,g/ml. The clostridia other than Clostridium perfringens were the most resistant (84% inhibited at 32 ,ug/ml and 95% inhibited at 64 ,ug/ml).
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Many new beta-lactam antibiotics have been introduced in the last several years, many of which have limited activity against anaerobic bacteria (2, 3, 10, 13) . Apalcillin is a naphthyridine derivative of ampicillin which has been reported to have levels of activity comparable to those of other broad-spectrum penicillin derivatives (e.g., azlocillin, mezlocillin, and piperacillin) against a wide range of organisms and particularly good activity against Pseudomonas aeruginosa (12) . Cefpiramide (SM-1652) is a semisynthetic cephalosporin whose structure, antibacterial activity, and stability to P-lactamases have been described previously (4) . Cefpiramide has been reported to have excellent activity against P. aeruginosa (4, 7, 9) . The purpose of this study was to investigate the activities of these two new antimicrobial agents against a wide range of anaerobic bacteria, with particular attention to the Bacteroides fragilis group, which exhibits resistance to many of the newly developed antimicrobial agents. Cefpiramide was also relatively weak in activity against the B. fragilis group; 22% (16 of 74) of strains of the B. fragilis group were resistant even at 128 ,ug/ml (10 of 37 B. fragilis strains, 3 of 18 B. thetaiotaomicron strains, 2 of 6 B. distasonis strains, and 1 of 5 B. vulgatus strains). Cefpiramide has been reported to be sensitive to the 3-lactamases of the B. fragilis group, which are classified as cefuroximehydrolyzing enzymes (7) . Of the other Bacteroides species, only B. capillosus exhibited significant resistance to cefpiramide. Cefpiramide was quite effective against the clostridia, excellent against the fusobacteria and cocci, and very active against gram-positive nonsporeforming rods, with only the Eubacterium lentum strains showing marked resistance (four of five strains were inhibited only at 128 pug/ml). These results correlate well with those reported previously (7, 9) .
MATERIALS AND METHODS
In comparing the antibacterial activities against B. fragilis of the five antibiotics tested at achievable levels in serum CEFPIRAMIDE AND APALCILLIN AGAINST ANAEROBES 163 
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( (6, 14) , and piperacillin (11) than was found in this study. Earlier studies from this laboratory yielded higher percentages of B. fragilis strains susceptible to piperacillin and cefoxitin (13) . All five antimicrobial agents were approximately equally active against other Bacteroides species (90 to 97%).
All five drugs had excellent activities against Clostridium perfringens; apalcillin and piperacillin had excellent (100%) activities against clostridial species other than C. perfringens or C. difficile, whereas the other three antimicrobial agents showed good activities (80 to 88%) against this group. Apalcillin and piperacillin were the most active (100%) against C. difficile, cefpiramide had good (87%) activity, and moxalactam and cefoxitin were relatively inactive, as expected.
The results of this study correlate well with previous work done in our laboratory, with certain notable differences. In a previous study (13) , Rolfe and Finegold found that cefoxitin inhibited 91% of anaerobic strains tested at its breakpoint of 32 ,ug/ml. Sutter and Finegold (16) found that 93% of anaerobes were inhibited at this concentration. In our study, cefoxitin inhibited 83% of anaerobic strains tested, with the notable difference occurring in the inhibition of C. difficile. When C. difficile is eliminated from the calculations, cefoxitin inhibited 92% of anaerobic strains in the present study. Moxalactam inhibited 79% of anaerobic strains overall, showing an excellent correlation with previous work (13); additionally, the correlation extends to the percentage of inhibition of individual species or groups.
The only notable exceptions in this study involve the fusobacteria. In a previous paper, Rolfe and Finegold (13) reported that 20% of strains of Fusobacterium mortiferum and F. varium were resistant to cefoxitin and moxalactam at their breakpoints, whereas in our study all of the fusobacteria were susceptible at these levels. The discrepancies are not due to differences in the random sampling of strains. Rather, the pattern of growth of several Fusobacterium strains exhibits confusing results in susceptibility patterns. Heavy growth is inhibited at the concentrations reported in this study; a haze (with visible, tiny, discrete colonies) persists at concentrations of up to 256 ,ug/ml with a few strains of F. varium and F. mortiferum. Studies are under way to clarify the nature of this growth, but preliminary observations indicate that this growth may represent cell wall-deficient forms of fusobacteria. This phenomenon has been reported earlier with fusobacteria (17) .
These data indicate that although apalcillin and cefpiramide are of limited value against the B. fragilis group, their level of activity against most other anerobes compares favorably with that of the other antimicrobial agents tested.
